Roth MKM analyst Leo Mariani lowered the firm’s price target on CNX Resources (CNX) to $28 from $30. The firm keeps a Neutral rating on the ...

Roth MKM analyst Scott Searle raised the firm’s price target on Calix (CALX) to $48 from $44 and keeps a Buy rating on the shares. The company ...

Roth MKM raised the firm’s price target on TKO Group (TKO) to $185 from $148 and keeps a Buy rating on the shares. The firm remains positive on ...

These four Buy-rated stocks are trading under $10 and could offer patient investors enormous returns for 2025 and beyond.

In terms of valuation, Mind Medicine (MindMed) Inc’s market capitalization stands at $544.86 million. Market cap represents the total value of all outstanding shares and is a key indicator of a ...

Hecla Mining Co (HL) stock saw a modest uptick, ending the day at $5.39 which represents a slight increase of $0.06 or 1.13% from the prior close of $5.33. The stock opened at $5.36 and touched a low ...

We recently published a list of 10 Unstoppable Stocks to Buy in 2025. In this article, we are going to take a look at where ...

Roblox (NYSE:RBLX – Free Report) had its target price lifted by Roth Mkm from $54.00 to $70.00 in a research report report ...

Roth Mkm restated their buy rating on shares of TriSalus Life Sciences (NASDAQ:TLSI – Free Report) in a research report ...

https://www.tipranks.com/news/the-fly/visteon-price-target-lowered-to-115-from-140-at-barclays Roth MKM lowered the firm’s price target on Mattel (MAT) to $20 from ...

Friday - Shares of Verona Pharma (NASDAQ:VRNA) received a positive outlook from Roth/MKM as the firm initiated coverage with a Buy rating and a 12-month price target of $68. The bullish stance is ...

Fintel reports that on January 10, 2025, Roth MKM initiated coverage of Verona Pharma plc - Depositary Receipt () (NasdaqGM:VRNA) with a Buy recommendation. Analyst Price Forecast Suggests 5.90% ...